Business Context and Reporting Period
This Form 8-K Current Report was filed by Lifemd, Inc. on July 19, 2021. The filing discloses a material amendment to the employment agreement of a senior executive, specifically the Chief Acquisition Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation adjustments.
Material Changes
Effective July 19, 2021, Lifemd, Inc. entered into the First Amendment to the Amended and Restated Employment Agreement with Nicholas Alvarez, Chief Acquisition Officer. The material changes include:
- Base Salary Increase: Raised from $172,400 to $300,000 per year.
- Performance Bonus: Specified a discretionary Performance Bonus of up to $125,000.
- Governing Law: Changed to New York.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of risks and contingencies. It is a procedural disclosure regarding executive compensation terms.
Investor Verification Checklist
- Verify the full text of the First Amendment (Exhibit 10.1) for specific performance metrics tied to the $125,000 bonus.
- Confirm the impact of the increased fixed compensation ($127,600 annual increase) on the company's operating expenses.
- Review the original December 8, 2020, employment agreement to understand the baseline terms prior to this amendment.